WRF
CRSP icon

Waddell & Reed Financial’s CRISPR Therapeutics CRSP Stock Holding History

Waddell & Reed Financial’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$131M Sell
1,071,487
-142,615
-12% -$21.5M 0.27% 108
2020
Q4 		$186M Sell
1,214,102
-98,381
-7% -$11.6M 0.39% 62
2020
Q3 		$110M Buy
1,312,483
+285,151
+28% +$25.3M 0.26% 104
2020
Q2 		$75.5M Buy
1,027,332
+7
+0% +$409 0.2% 136
2020
Q1 		$43.6M Buy
1,027,325
+5
+0% +$258 0.14% 171
2019
Q4 		$62.6M Sell
1,027,320
-19,008
-2% -$1.04M 0.16% 172
2019
Q3 		$42.9M Buy
1,046,328
+44,410
+4% +$2.12M 0.11% 211
2019
Q2 		$47.2M Hold
1,001,918
– – 0.12% 214
2019
Q1 		$35.8M Buy
1,001,918
+1,918
+0.2% +$66.3K 0.09% 266
2018
Q4 		$28.6M Hold
1,000,000
– – 0.08% 277
2018
Q3 		$44.4M Buy
+1,000,000
New +$52.4M 0.1% 239

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return